thalidomide has been researched along with Diverticulitis in 1 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Diverticulitis: Inflammation of a DIVERTICULUM or diverticula.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sriskandarajah, P | 1 |
Scott, F | 1 |
Muthalali, S | 1 |
Mercieca, J | 1 |
1 other study available for thalidomide and Diverticulitis
Article | Year |
---|---|
Life-threatening bowel perforation while on thalidomide-based triplet regimen for multiple myeloma: a retrospective case series.
Topics: Aged; Aged, 80 and over; Diverticulitis; Female; Humans; Intestinal Perforation; Male; Middle Aged; | 2016 |